For the Inventor, By the Inventor

Enter assignee name

Burlington, MA, United States of America

Scpharmaceuticals Inc.

Calculating rank

USPTO Granted Patents = 14

EPO Patents = 4

Trademarks = 3

Forward Citations = 33

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

Franciscus Koppenhagen (10 out of 13 patents)

Alfredo Grossi (10 out of 10 patents)

Britt Kostraba (10 out of 10 patents)

4. Shannon Terry (10 out of 10 patents)

5. Olatokumbo Olajimi Luca Ogunleye (6 out of 6 patents)

6. Pieter Muntendam (4 out of 11 patents)

7. Scott A Michaels (4 out of 4 patents)

8. Olatokumbo O Luca Ogunleye (4 out of 4 patents)

9. Glenn R Larsen (4 out of 30 patents)

10. Michael Hassman (0 patent)

11. John F Mohr, Iii (0 patent)

12. Erik Mark Pecorelli (0 patent)

13. Bhavini Patel (0 patent)

14. Phani Kamineni (0 patent)

15. John Tucker (0 patent)

14 patents: Sort by Forward Citations

1. 12491197 - Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same (2025-12-09),

2. 12491196 - Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same (2025-12-09),

3. 12491195 - Concentrated liquid pharmaceutical Formulations of furosemide and methods of administering the same (2025-12-09),

4. 12491194 - Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same (2025-12-09),

5. 12491193 - Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same (2025-12-09),

6. 12370168 - Pharmaceutical formulations for subcutaneous administration of furosemide (2025-07-29),

7. 12048709 - Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same (2024-07-30),

8. 11998555 - Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same (2024-06-04),

9. 11571434 - Concentrated liquid pharmaceutical formulations of furosemide (2023-02-07),

10. 11559535 - Concentrated liquid pharmaceutical formulations of furosemide (2023-01-24),

11. 11497755 - Concentrated liquid pharmaceutical formulations of furosemide (2022-11-15),

12. 11433044 - Pharmaceutical formulations for subcutaneous administration of furosemide (2022-09-06),

13. 10272064 - Pharmaceutical formulations for subcutaneous administration of furosemide (2019-04-30),

14. 9884039 - Pharmaceutical formulations for subcutaneous administration of furosemide (2018-02-06),

Company Overview

Scpharmaceuticals Inc. is a biopharmaceutical company based in Burlington, Massachusetts, focused on developing innovative therapies for patients with serious medical conditions. The company specializes in the formulation and delivery of injectable medications, aiming to enhance patient care through improved treatment options. Scpharmaceuticals leverages advanced technology to create products that address unmet medical needs, particularly in the areas of chronic and acute diseases, thereby contributing to the evolution of modern healthcare.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

14 Patents

#44 in Burlington, MA

#1,364 in Massachusetts

#22,344 in US

#42,312 in the World

Burlington, MA, United States of America

Scpharmaceuticals Inc.

Forward Citations = 33

9 inventors:

Franciscus Koppenhagen (10 out of 13 patents)

Alfredo Grossi (10 out of 10 patents)

Britt Kostraba (10 out of 10 patents)

4. Shannon Terry (10 out of 10 patents)

5. Olatokumbo Olajimi Luca Ogunleye (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Scpharmaceuticals Inc.. Retrieved from https://idiyas.com/company/scpharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…